Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Moderna Therapeutics
Moderna Therapeutics
Activities:
Research & Development
Cardiovascular
Digestion
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Moderna announces positive phase 1/2 data for vaccine against Covid-19
Moderna has shared positive phase 1/2 data for its breakthrough combination vaccine against Influenza and Covid-19
Research & Development
How serious is the Pirola strain?
Following the recent news of gradually increasing cases of the new COVID-19 variant Pirola, we sat down with Moderna's VP of Medical Affairs Cesar Sanz Rodriguez to discuss just what people can expect in the coming months
Distribution
Moderna receives positive opinion from the EMA for Spikevax
Moderna has revealed the European Medicine's Agency (EMA) has provided positive opinion on its COVID-19 vaccine Spikevax's marketing authorisation
Research & Development
Moderna discusses mRNA technology advances
Announcements on its mRNA tech, vaccine characterisation and biodistribution were made during the company’s Science and Technology Day event
Regulatory
Moderna senior executive to speak at the ISPE conference
As Chief Technical Operations and Quality Officer, Andres is responsible for the supply of products required for the company’s preclinical and clinical development programmes
Manufacturing
Moderna and Thermo Fisher sign long-term manufacturing agreement
Thermo Fisher will provide dedicated capacity for fill-finish services, in addition to inspection, labelling and packaging
Manufacturing
National Resilience to manufacture mRNA for Moderna vaccine
Under the terms of the multi-year agreement, Resilience will produce mRNA for the COVID-19 vaccine at its facility in Mississauga, Ontario in Canada
Subscribe now